Please update your web browser or disable Compatibility View.

Wicka '90 Uses Entrepreneurial Skills to Develop New Drug

Bookmark and Share

December 27, 2011

The Wall Street Journal recently featured Tom Wicka, who purchased a developing drug and is using his entrepreneurial skills to control operations. Wicka hopes to launch a clinical trial next year with the goal of developing a drug that will alleviate Duchenne muscular dystrophy. Wicka's son, Nash, suffers from the genetic neuromuscular disorder which primarily strikes boys and currently has no cure.

The Wall Street Journal